Latest Breaking News On - Cristi barnett - Page 1 : comparemela.com

Editas Medicine to Present Clinical Data from the RUBY and EdiTHAL Trials of Reni-cel at the European Hematology Association 2024 Congress in June

Editas Medicine to Present Clinical Data from the RUBY and EdiTHAL Trials of Reni-cel at the European Hematology Association 2024 Congress in June
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomHaydar frangoulHall velasquezCristi barnettRabi hannaBaisong meiEuropean hematology associationHarvard university casExchange commissionEditas medicine incEuropean hematology association congressDepartment of pediatric hematology oncologyBroad instituteBroad institute casPresent clinical data

Editas Medicine, Inc (NASDAQ:EDIT) Q1 2024 Earnings Call Transcript

Editas Medicine, Inc (NASDAQ:EDIT) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United statesBrian chengMary kateErick luceraSamantha semenkowCristi barnettLinda burklyBristol myers squibbGreg whiteheadGilmore oneillMani forooharJack allenJoon leeEmmanuelle charpentierCaren deardorfBaisong mei

Editas Medicine Announces First Quarter 2024 Results and Business Updates

Editas Medicine Announces First Quarter 2024 Results and Business Updates
eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkUnited kingdomCristi barnettGregory whiteheadVivo hemoglobinopathiesEmmanuelle charpentierBristol myers squibbGilmore oneillLas vegasEditas medicine incBroad institute casUniversity of viennaVertex pharmaceuticals incorporatedGenetic medicines forumHarvard university cas

Editas Medicine, Inc (NASDAQ:EDIT) Q4 2023 Earnings Call Transcript

Editas Medicine, Inc. beats earnings expectations. Reported EPS is $-0.23, expectations were $-0.52.

United statesGreg harrisonLinda burklyGilmore oneillBaisong meiCaren deardorfBrian chengErick luceraJoon leeCristi barnettSamantha semenkowCorporate communicationsEditas medicine incVertex pharmaceuticalsEditas medicineCall transcript february

Editas Medicine, Inc (NASDAQ:EDIT) Q4 2023 Earnings Call Transcript

Editas Medicine, Inc. beats earnings expectations. Reported EPS is $-0.23, expectations were $-0.52.

United statesCristi barnettSamantha semenkowBrian chengErick luceraJoon leeBaisong meiGilmore oneillCaren deardorfGreg harrisonLinda burklyEditas medicine incCorporate communicationsVertex pharmaceuticalsMost valuable electric car companiesEditas medicine